AMCo Historyfrom the Sept 8 NR: High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email ftsales.support@ft.com to buy additional rights. https://www.ft.com/cms/s/0/a2dd2cae-55fe-11e5-a28b-50226830d644.html#ixzz3t0CLP8kY AMCo, a producer of niche generic prescription drugs, was formed from Cinvens merger of UK-focused Mercury Pharma with Amdipharm, both bought in 2012. The company doubled earnings before taxes, interest, depreciation and amortisation in the three years of Cinvens ownership, acquiring five other businesses to expand its international presence. AMCos core underlying business has driven double-digit top-line and bottom-line growth, Mr Rajagopalan said. ... so there is a history of sales at AMCo division. Forecast growth is only in the high single digits. This is why CXR will likely surprise to the upside.. again.